Outset Medical, Inc.
OM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -6.3% | 5.6% | 1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 39.4% | 37.8% | 37.2% | 36.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -46.3% | -53.7% | -70% | -62.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -60.6% | -59% | -86.7% | -87% |
| EPS Diluted | -1 | -1.04 | -7.44 | -0.5 |
| % Growth | 3.8% | 86% | -1,388% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |